(1)
Hereditary Angioedema Type 1, Limitations for Prophylactic Therapy With Lanadelumab: Regarding a Case. Rev Alerg Mex 2024, 71 (4), 264-267. https://doi.org/10.29262/ram.v71i4.1323.